FDG PET for Brain, Cervical, Ovarian, Pancreatic, Small Cell Lung, and Testicular Cancers (Replaced with Section 220.6.17) - RETIRED

This policy (NCD295 / section 220.6.14) is retired and was removed from the NCD Manual; it was replaced by section 220.6.17 effective April 3, 2009, with retirement effective April 10, 2023. There are no active coverage criteria in this document for FDG PET in brain, cervical, ovarian, pancreatic, small cell lung, or testicular cancers; refer to NCD 220.6.17 for current coverage guidance.

"Section 220."

Sign up to see full coverage criteria, indications, and limitations.